Clinical Trial Update: A Phase 1/2 Study to Investigate Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of HMB-001 in Glanzmann Thrombasthenia [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating safety, tolerability, pharmacokinetics, pharmacodynamics, and efficacy of HMB-001 in Glanzmann thrombasthenia; status is a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glanzmann Thrombasthenia

Drugs mentioned

• HMB-001

Snippet

Sponsor: Hemab ApS | Conditions: Glanzmann Thrombasthenia | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING